1. Home
  2. NTRA vs WSM Comparison

NTRA vs WSM Comparison

Compare NTRA & WSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NTRA
  • WSM
  • Stock Information
  • Founded
  • NTRA 2003
  • WSM 1956
  • Country
  • NTRA United States
  • WSM United States
  • Employees
  • NTRA N/A
  • WSM N/A
  • Industry
  • NTRA Medical Specialities
  • WSM Home Furnishings
  • Sector
  • NTRA Health Care
  • WSM Consumer Discretionary
  • Exchange
  • NTRA Nasdaq
  • WSM Nasdaq
  • Market Cap
  • NTRA 24.9B
  • WSM 24.3B
  • IPO Year
  • NTRA 2015
  • WSM N/A
  • Fundamental
  • Price
  • NTRA $192.81
  • WSM $195.49
  • Analyst Decision
  • NTRA Strong Buy
  • WSM Buy
  • Analyst Count
  • NTRA 17
  • WSM 16
  • Target Price
  • NTRA $196.24
  • WSM $198.50
  • AVG Volume (30 Days)
  • NTRA 1.1M
  • WSM 977.5K
  • Earning Date
  • NTRA 11-07-2025
  • WSM 11-19-2025
  • Dividend Yield
  • NTRA N/A
  • WSM 1.35%
  • EPS Growth
  • NTRA N/A
  • WSM 9.54
  • EPS
  • NTRA N/A
  • WSM 9.01
  • Revenue
  • NTRA $1,964,250,000.00
  • WSM $7,829,759,000.00
  • Revenue This Year
  • NTRA $24.17
  • WSM $2.64
  • Revenue Next Year
  • NTRA $15.57
  • WSM $3.22
  • P/E Ratio
  • NTRA N/A
  • WSM $21.69
  • Revenue Growth
  • NTRA 44.38
  • WSM 3.28
  • 52 Week Low
  • NTRA $119.29
  • WSM $125.33
  • 52 Week High
  • NTRA $198.99
  • WSM $219.98
  • Technical
  • Relative Strength Index (RSI)
  • NTRA 68.54
  • WSM 53.51
  • Support Level
  • NTRA $183.88
  • WSM $185.13
  • Resistance Level
  • NTRA $198.99
  • WSM $203.78
  • Average True Range (ATR)
  • NTRA 6.55
  • WSM 5.91
  • MACD
  • NTRA 1.09
  • WSM 1.05
  • Stochastic Oscillator
  • NTRA 80.07
  • WSM 62.88

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

About WSM Williams-Sonoma Inc. (DE)

With a retail and direct-to-consumer presence, Williams-Sonoma is a player in the $300 billion domestic home category and $450 billion international home market, focused on expanding its exposure in the B2B ($80 billion total addressable market), marketplace, and franchise areas. Namesake Williams-Sonoma (154 stores) offers high-end cooking essentials, while Pottery Barn (181) provides casual home accessories. West Elm (119) is an emerging concept for young professionals, and Rejuvenation (11) offers lighting and house parts. Brand extensions include Pottery Barn Kids and Pottery Barn Teen (44) as well as Mark & Graham and GreenRow. Williams-Sonoma also has a business-to-business team that supports projects that range from residential to large-scale commercial.

Share on Social Networks: